originally published Thursday, February 28, 2019

Printable Version

All Biotech & Medical Stocks

We last bought Avivagen at C$0.53 over a week ago, and with it now at about C$0.80, we are up about 48% since then. As it is arriving at a zone of considerable resistance in an extremely overbought state, it is considered prudent to TAKE PROFITS HERE and await developments. We can buy it back on a reaction, if there is one. More details on the charts below.

Avivagen Inc website

Avivagen Inc, VIV.V, CHEXF on OTC, trading at at C$0.80, $0.603 at 3.24 pm on 28th February 19.

Posted at 3.52 pm EST on 28th February 19.

FOOTNOTE: Due to technical problems this article was posted later than intended, giving you very little time to take action before the close of trading. By the look of it some of you took profits in the morning, which meant you got an even better price.

The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stockmarket analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.